Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

ONTX Financial Statements and Analysis

NASDAQ : ONTX

Onconova Therapeutics, Inc.

$1.00
-0.0047-0.47%
Open: 4:00 PM
Not Actively Trading
67.34
BESG ScoreESG Rating

ONTX FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ONTX Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
revenue56.00K56.00K57.00K57.00K56.00K
cost of revenue005.00K4.00K3.00K
gross profit56.00K56.00K52.00K53.00K53.00K
gross profit ratio1.001.000.9120.930.946
research and development expenses1.912M2.434M2.46M2.456M4.08M
general and administrative expenses3.356M2.084M2.686M2.211M2.113M
selling and marketing expenses00000
selling general and administrative expenses3.356M2.084M2.686M2.211M2.113M
other expenses229.00K278.00K350.00K360.00K362.00K
operating expenses5.268M4.518M5.146M4.667M6.193M
cost and expenses5.268M4.518M5.146M4.667M6.193M
interest income00000
interest expense0000-362.00K
depreciation and amortization4.00K4.00K5.00K4.00K3.00K
ebitda-5.208M-4.458M-5.084M-4.61M-6.134M
ebitda ratio-93.00-79.607-89.193-80.877-109.536
operating income-5.212M-4.462M-5.089M-4.61M-6.137M
operating income ratio-93.071-79.679-89.281-80.877-109.589
total other income expenses net229.00K278.00K350.00K360.00K362.00K
income before tax-4.983M-4.184M-4.739M-4.25M-5.775M
income before tax ratio-88.982-74.714-83.14-74.561-103.125
income tax expense000-4.00K-362.00K
net income-4.983M-4.184M-4.739M-4.25M-5.413M
net income ratio-88.982-74.714-83.14-74.561-96.661
eps-0.240-0.23-0.20-0.26
eps diluted-0.240-0.23-0.20-0.26
weighted average shs out21.043M021.003M20.98M20.96M
weighted average shs out dil21.043M021.003M20.98M20.96M
Graph

ONTX Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
cash and cash equivalents16.39M20.821M25.244M29.729M34.22M
short term investments00000
cash and short term investments16.39M20.821M25.244M29.729M34.22M
net receivables18.00K18.00K18.00K17.00K17.00K
inventory1.482M1.42M1.446M98.00K734.00K
other current assets263.00K401.00K303.00K704.00K68.00K
total current assets18.153M22.66M27.011M30.45M35.039M
property plant equipment net18.00K22.00K26.00K17.00K21.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets1.00K1.00K1.00K1.00K1.00K
total non current assets19.00K23.00K27.00K18.00K22.00K
other assets00000
total assets18.172M22.683M27.038M30.468M35.061M
account payables6.568M5.619M6.148M5.071M4.896M
short term debt00000
tax payables00000
deferred revenue226.00K226.00K226.00K226.00K226.00K
other current liabilities2.628M3.375M3.30M3.369M4.102M
total current liabilities9.422M9.22M9.674M8.666M9.224M
long term debt00000
deferred revenue non current2.735M2.791M2.847M2.904M2.961M
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities2.735M2.791M2.847M2.904M2.961M
other liabilities00000
capital lease obligations00000
total liabilities12.157M12.011M12.521M11.57M12.185M
preferred stock00000
common stock211.00K210.00K210.00K210.00K210.00K
retained earnings-487.614M-482.631M-478.447M-473.708M-469.458M
accumulated other comprehensive income loss-30.00K-23.00K-30.00K-28.00K-27.00K
other total stockholders equity493.448M493.116M492.784M492.424M492.151M
total stockholders equity6.015M10.672M14.517M18.898M22.876M
total equity6.015M10.672M14.517M18.898M22.876M
total liabilities and stockholders equity18.172M22.683M27.038M30.468M35.061M
minority interest00000
total investments00000
total debt00000
net debt-16.39M-20.821M-25.244M-29.729M-34.22M
Graph

ONTX Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
deferred income tax00706.00K72.00K706.00K
stock based compensation333.00K332.00K360.00K273.00K336.00K
change in working capital222.00K-582.00K-95.00K-517.00K893.00K
accounts receivables00-1.00K012.00K
inventory001.00K00
accounts payables949.00K-529.00K1.077M175.00K1.036M
other working capital-56.00K-53.00K-1.172M-692.00K-155.00K
other non cash items00-706.00K-72.00K-706.00K
net cash provided by operating activities-4.424M-4.43M-4.469M-4.49M-4.543M
investments in property plant and equipment00-14.00K00
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00-14.00K00
debt repayment00000
common stock issued00000
common stock repurchased00000
dividends paid00000
other financing activites00000
net cash used provided by financing activities00000
effect of forex changes on cash-7.00K7.00K-2.00K-1.00K6.00K
net change in cash-4.431M-4.423M-4.485M-4.491M-4.537M
cash at end of period16.39M20.821M25.244M29.729M34.22M
cash at beginning of period20.821M25.244M29.729M34.22M38.757M
operating cashflow-4.424M-4.43M-4.469M-4.49M-4.543M
capital expenditure00-14.00K00
free cash flow-4.424M-4.43M-4.483M-4.49M-4.543M
Graph

Frequently Asked Questions

How did Onconova Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ONTX generated $56.00K in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Onconova Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Onconova Therapeutics, Inc. reported a $56.00K Gross Profit for the quarter ended Mar 31, 2024.
Have ONTX's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ONTX incurred $5.27M worth of Operating Expenses, while it generated -$5.21M worth of Operating Income.
How much Net Income has ONTX posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Onconova Therapeutics, Inc., the company generated -$4.98M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Onconova Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Onconova Therapeutics, Inc. as of the end of the last quarter was $16.39M.
What are ONTX's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ONTX had Total Net Receivables of $18.00K.
In terms of Total Assets and Current Assets, where did Onconova Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ONTX were $18.15M, while the Total Assets stand at $18.17M.
As of the last quarter, how much Total Debt did Onconova Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ONTX's debt was $0.00 at the end of the last quarter.
What were ONTX's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ONTX reported total liabilities of $12.16M.
How much did ONTX's Working Capital change over the last quarter?
Working Capital Change for ONTX was $222.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ONTX generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ONTX generated -$4.42M of Cash from Operating Activities during its recently reported quarter.
What was ONTX's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ONTX reported a -$4.43M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph